The University of Hong Kong-Shenzhen Hospital ( Site 3930)

Shenzhen, Guangdong 518053

1 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease

Studies at this site

• A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008) — Recruiting now